Pharmacist Moms Group^™

Reducing alcohol intake alongside GLP-1 therapy may significantly improve outcomes for patients with obesity or diabetes risk.

Ben Long, MD, and Weston Blakeslee, PhD, discuss how pharmacists can integrate automated SMS tools to reduce readmissions while minimizing workflow burden.

Explore how pneumococcal vaccine efficacy is measured, its real-world impact, and the importance of immunobridging for informed vaccination decisions.

On Chen, MD, and Tahmid Rahman, MD, explain the real-world safety, dosing advantages, and pharmacist-driven identification strategies for patients who may benefit from plozasiran therapy.

In this episode, the panel explains how VMAT2 inhibitors became the foundation of modern tardive dyskinesia treatment.

Healthcare professionals discuss effective management strategies for breakthrough bleeding, emphasizing updated protocols and patient education for optimal outcomes.

This episode outlines all treatment approaches available for tardive dyskinesia and how they are applied in practice.

Explore the evolving landscape of bleeding management with new rebalancing agents, emphasizing lower doses and effective treatment strategies.

Plozasiran offers a novel RNA-based mechanism to significantly reduce triglyceride levels in patients with familial chylomicronemia syndrome.